HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.

AbstractBACKGROUND:
Dendritic cells (DCs) acquire, during their maturation, the expression of the chemokine receptor CCR7 and the ability to migrate to lymph nodes in response to CC chemokine ligand 19 (CCL19). This migration is impaired in mice lacking the leukotriene (LT) C4 transporter and restored by addition of exogenous LTC4.
OBJECTIVE:
To define the role of LT in human DC function, we studied the expression and function of the cysteinyl-leukotriene (CysLT) receptors during DC differentiation from monocytes and subsequent maturation.
METHODS:
Receptor expression was measured by flow cytometry and real-time PCR. Responsiveness to LTD4 stimulation was assessed by calcium flux and chemotaxis.
RESULTS:
Maturation of DC with LPS, a classic Toll-like receptor 4 agonist, reduced CysLT receptor 1 (CysLT1) expression by 50%, whereas CysLT receptor 2 expression was increased. In contrast, the Toll-like receptor 3 agonist poly inosinic and cytidylic acid (polyI:C) had no effect on receptor expression. Downregulation of CysLT1 expression by LPS could not be mimicked by TNF-alpha alone or in combination with IL-1beta or IL-6. It was, however, prevented by inhibitors of COX and could be reproduced by a combination of TNF-alpha and prostaglandin E2. Immature DCs and DCs matured with polyI:C, but not with LPS, responded to LTD4 with a robust cytosolic calcium flux, which was prevented by the CysLT1 antagonist montelukast. LTD4 induced DC chemotaxis and enhanced DC migration in response to CCL19 in DCs matured with polyI:C, but only weakly in DCs matured with LPS.
CONCLUSION:
Our data suggest that human DCs may differentially respond to leukotriene, depending on their maturational stimuli.
CLINICAL IMPLICATIONS:
Our study demonstrates that some microbial agents can reduce the migration of dendritic cells in response to leukotrienes, with potential for differential involvement of these cells in allergic inflammation.
AuthorsMaryse Thivierge, Jana Stankova, Marek Rola-Pleszczynski
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 117 Issue 5 Pg. 1155-62 (May 2006) ISSN: 0091-6749 [Print] United States
PMID16675346 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Leukotrienes
  • Membrane Proteins
  • Receptors, Leukotriene
  • Toll-Like Receptors
  • cysteinyl-leukotriene
  • Leukotriene C4
  • Leukotriene D4
  • Cysteine
  • leukotriene D4 receptor
  • Calcium
Topics
  • Calcium (metabolism)
  • Cells, Cultured
  • Chemotaxis, Leukocyte (immunology)
  • Cysteine (physiology)
  • Dendritic Cells (immunology, metabolism)
  • Humans
  • Leukotriene C4 (biosynthesis, physiology)
  • Leukotriene D4 (biosynthesis, physiology)
  • Leukotrienes (physiology)
  • Membrane Proteins (genetics, metabolism)
  • Receptors, Leukotriene (genetics, metabolism)
  • Toll-Like Receptors (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: